Analytical Data
-
Gene name
FAM3D
- Application
-
Alternative Names
EF7; OIT1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96BQ1
-
Expression Region
Tyr26~Phe224
-
Molecular Weight
26kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM3D, or Family with Sequence Similarity 3 Member D, is a novel protein that has garnered attention in biomedical research due to its potential roles in various physiological and pathological processes. Emerging studies have indicated that FAM3D may be involved in regulating immune responses, cell proliferation, and differentiation, making it a key candidate for understanding immune-related disorders and cancers. Its expression patterns in different tissues suggest that FAM3D is crucial in maintaining cellular homeostasis, while aberrant levels have been linked to inflammatory diseases and certain malignancies. Researchers are focusing on recombinant FAM3D protein to dissect its structure-function relationships and molecular mechanisms of action. This recombinant protein can be utilized in various assays, including binding studies and functional analyses, to elucidate its role in cellular pathways. Furthermore, understanding FAM3D's interactions with other biomolecules could provide insights into therapeutic targets, particularly for diseases where FAM3D expression is dysregulated. The development of FAM3D as a recombinant protein thus opens avenues for both basic research and potential clinical applications, highlighting its significance in the landscape of modern molecular biology. With ongoing investigations, FAM3D represents a promising frontier for advancing knowledge in immunology and oncology.
